ILLUMINA INC
For the period ended Dec 29, 2024. Filed Feb 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
The following table, excluding GRAIL which was spun-off on June 24, 2024, summarizes the facilities we leased as of December 29, 2024, including location and size of each principal facility and designated use. We believe our facilities are adequate for our current and near-term needs, and we will be able to locate additional facilities, as needed.
| Location | Approximate Square Feet | Operation | Lease Expiration Dates |
|---|---|---|---|
| San Diego, CA | 860,000 | Office, Lab, Manufacturing, and Distribution | 2030 – 2031 |
| Singapore | 584,000 | Office, Lab, Manufacturing, and Distribution | 2027 – 2037 |
| San Francisco Bay Area, CA | 269,000 | Office, Lab, and Manufacturing | 2025 – 2033 |
| Cambridge, United Kingdom | 181,000 | Office, Lab, and Manufacturing | 2025 – 2038 |
| Madison, WI | 133,000 | Office, Lab, and Manufacturing | 2033 |
| Eindhoven, the Netherlands | 90,000 | Office and Distribution | 2036 |
| China | 86,000 | Office and Lab | 2026 – 2028 |
| India | 66,000 | Office and Lab | 2027 – 2029 |
| Other | 140,000 | Office and Lab | 2025 – 2030 |
Human Capital
To continue as a leader in genomics, we need to harness the world’s best talent and give them the opportunity to thrive. We are committed to attracting, retaining, developing, and supporting our people to enable everyone to fully contribute to our mission and deliver on the transformative power of genomics. We drive innovation by embracing new perspectives and making Illumina a place where everyone can belong. Our key human capital objectives include: attract extraordinary talent, invest in our people, support employee health, safety, and well-being, and engage our people and communities. Additional information is included in our annual Corporate Social Responsibility (CSR) Report, located on our website at www.illumina.com/csr. Information on our website, including the CSR Report, shall not be deemed incorporated by reference into this Annual Report. Our annual CSR Report is guided by the reporting frameworks of the Global Reporting Initiative (GRI), Sustainable Accounting Standards Board (SASB), and the Task Force for Climate related Financial Disclosures (TCFD).
As of December 29, 2024, excluding GRAIL which was spun-off on June 24, 2024, our global workforce was comprised of approximately 8,970 full time employees, 60 part time employees, and 1,340 contingent workers. The regional representation includes approximately 5,250 employees in the Americas, 1,290 employees in Europe, 2,190 employees in Africa, Middle East and Asia, and 300 employees in Greater China. The global voluntary turnover rate for 2024 was 7%. Additional details about our workforce for 2024 will be available in our annual CSR Report, which we expect to publish in May 2025 on our website at www.illumina.com/csr.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.